1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (1087)
  2. Meeting Abstract (890)
  3. Review (52)
  4. Book Section (46)
  5. Editorial (35)
  6. Guidelines (21)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)

More Groups

People
  1. Carol Aghajanian (607)
  2. Martee Hensley (289)
  3. Nadeem Abu-Rustum (288)
  4. Roisin O'Cearbhaill (271)
  5. Vicky Makker (263)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (41)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (450)
  2. Gynecologic Oncology (418)
  3. International Journal of Gynecological Cancer (154)
  4. Annals of Oncology (116)
  5. Clinical Cancer Research (67)
  6. Cancer Research (55)

More Publications

Publishers
  1. Elsevier Inc. (542)
  2. American Society of Clinical Oncology (489)
  3. Lippincott Williams & Wilkins (181)
  4. American Association for Cancer Research (168)
  5. Oxford University Press (143)
  6. Nature Publishing Group (86)

More Publishers

Results (2146)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized multicenter double-blind phase II trial: The immunological adjuvant OPT-821 with or without a trivalent ganglioside vaccine in metastatic sarcoma patients following metastasectomy
    Meeting Abstract

    Carvajal, R. D.; Chugh, R.; Milhem, M. M.; Ryan, C. W.; George, S.; Chmielowski, B.; Agulnik, M.; Rodler, E. T.; Elias, A. D.; Budd, G. T.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • An updated safety analysis of OCEANS, a randomized, double-blind, phase III trial of gemcitabine (G) and carboplatin (C) with bevacizumab (BV) or placebo (PL) followed by BV or PL to disease progression (PD) in patients with platinum-sensitive (Plat-S) recurrent ovarian cancer
    Meeting Abstract

    Aghajanian, C.; Blank, S. V.; Goff, B. A.; Judson, P. L.; Nycum, L. R.; Sovak, M. A.; Yi, J.; Husain, A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Uterine sarcomas: Histology and its implications on therapy
    Journal Article

    Hensley, M. L.
    American Society of Clinical Oncology Educational Book (2012)

    Fulltext@MSK | Save
  • Is there a role for bevacizumab in the primary treatment of advanced ovarian cancer off-protocol?
    Journal Article

    Meisel, J. L.; Sabbatini, P.
    Clinical Ovarian and other Gynecologic Cancer (2012)

    Fulltext@MSK | Save
  • Novel and targeted therapies
    Book Section

    Zauderer, M. G.; Traina, T. A.; Lichtman, S. M.
    In Naeim, A.; Reuben, D. B.; Ganz, P. A. (Eds.) Management of Cancer in the Older Patient (2012)

    Fulltext@MSK | Save
  • Phase i clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma
    Journal Article

    Konner, J.; Grisham, R. N.; Park, J.; O'Connor, O. A.; Cropp, G.; Johnson, R.; Hannah, A. L.; Hensley, M. L.; Sabbatini, P.; Mironov, S.; more...
    Investigational New Drugs (2012)

    Fulltext@MSK | Save
  • Reactive polyclonal gammopathy associated with polyclonal plasmacytosis is common in patients with multiple myeloma receiving prolonged lenalidomide therapy: A retrospective study of 104 patients
    Meeting Abstract

    Zamarin, D.; Devlin, S.; Arcila, M.; Giralt, S. A.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Chimento, D.; Babu, D.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Location of disease in patients who die from endometrial cancer : A study of 414 patients from a single institution
    Journal Article

    Barlin, J. N.; Wysham, W. Z.; Ferda, A. M.; Khoury-Collado, F.; Cassella, D.; Alektiar, K. M.; Hensley, M. L.; Chi, D. S.; Barakat, R. R.; Abu-Rustum, N. R.
    International Journal of Gynecological Cancer (2012)

    Fulltext@MSK | Save
  • Lymph node involvement: Indicator or instigator of poor outcome in stage III endometrial cancer?
    Meeting Abstract

    Milgrom, S. A.; Shih, K.; Abu Rustum, N.; Makker, V.; Gardner, G.; Barakat, R.; Alektiar, K. M.
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients
    Journal Article

    Sabbatini, P.; Tsuji, T.; Ferran, L.; Ritter, E.; Sedrak, C.; Tuballes, K.; Jungbluth, A. A.; Ritter, G.; Aghajanian, C.; Bell-Mcguinn, K.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save